Value Chain and CSR of Global Pharmaceutical Companies: A Framework to Define Practices

1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This chapter looks at the manner in which global pharmaceutical companies contribute to a better society. To answer this, the authors constructed a framework that allows the responsible practices deployed by the global pharmaceutical companies to be identified along the value chain. This framework offers a heuristic reasoning to facilitate the understanding of the cooperative strategies used by firms and describes the social obligations which companies think they must assume toward society. It is applied through an exploratory study filled with qualitative data obtained through corporate social responsibility (CSR) reports from 2013 of global pharmaceutical companies. At the end, the chapter offers examples from these companies to describe their CSR projects and derives an overall picture of pharmaceutical companies’ contribution toward society in the post-financial crisis.

Cite

CITATION STYLE

APA

Gimenes, N., & Payaud, M. A. (2017). Value Chain and CSR of Global Pharmaceutical Companies: A Framework to Define Practices. In Palgrave Studies in Governance, Leadership and Responsibility (Vol. Part F1750, pp. 199–220). Springer Nature. https://doi.org/10.1007/978-3-319-40096-9_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free